We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current 4BB market cap is 147.83M. The company's latest EPS is GBP -0.6222 and P/E is -19.29.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 430k | 567k | 421k | 335k | 984k |
| Operating Income | -420k | -1.09M | -3.2M | -4.9M | -7.48M |
| Net Income | -423k | -719k | -3.24M | -5.15M | -7.67M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 1.16M | 17.81M | 14.7M | 11.69M | 11.92M |
| Total Liabilities | 3.05M | 2.35M | 3.01M | 4.57M | 12.41M |
| Total Equity | -1.89M | 15.46M | 11.7M | 7.12M | -492k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | -269k | -1.02M | -2.74M | -4.7M | -6.18M |
| Investing | -203k | 1.45M | -1.51M | -1.94M | -1.49M |
| Financing | 488k | 14.43M | -467k | 1.24M | 6.43M |
| Market Cap | 147.83M |
| Price to Earnings Ratio | -19.29 |
| Price to Sales Ratio | 150.19 |
| Price to Cash Ratio | 48.17 |
| Price to Book Ratio | -300.47 |
| Dividend Yield | - |
| Shares Outstanding | 12.32M |
| Average Volume (1 week) | 371 |
| Average Volume (1 Month) | 593 |
| 52 Week Change | 81.82% |
| 52 Week High | 1,820.00 |
| 52 Week Low | 660.00 |
| Spread (Intraday) | 100 (8%) |
| Company Name | 4basebio Plc |
| Address |
25 norman way cambridgeshire CB24 5QE |
| Website | https://www.4basebio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
